VOLLTEXTSUCHE
Pressearchiv
Chameleon Pharma Consulting
Pressemitteilung

Report: ERBD invests in Russian pharmeceutical industry

(PM) Berlin, 05.03.2012 - Since their establishment in 1991 the ERBD (European Bank for Reconstruction and Development) has become the largest financial investor in their region of operations which stretches from central Europe and the Western Balkans to central Asia. With the ability and willingness to bear risk on behalf of their clients, in order to help countries in the region to become open market economies. The ERBD is owned by 63 countries, the European Union and the European Investment Bank.

Now the EBRD is going to buy a minority equity stake of around 15 per cent in Russia’s OSSC. Katren is one of the three largest national pharmaceutical distributers in Russia, Ukraine and Kazakhstan. This investment will give the EBRD the right to nominate two members for election to Katren´s board of directors. It is interesting to admit that prior to
this deal, the Bank had already invested over 300 Million Euro in the pharmaceutical industry in nine of the EBRD´s 29 countries of operation.

Chameleon Pharma Consulting comments: Katren has shown a very good performance over the last years and has worked its way up from a small local pharma distributor to a leading national TOP 3 player in Russia. It seems that the company is also one of the few Russian players, who has achieved a top position in Ukraine and Kazakhstan, beside their Russian base business. In this way companies are limiting the potential because of cultural issues between the countries.
PRESSEKONTAKT
Chameleon Pharma Consulting
Herr Reiner Christensen
Am Tempelhofer Berg 6
10965 Berlin
+49-30-64825164
E-Mail senden
Homepage
ZUM AUTOR
ÜBER CHAMELEON PHARMA CONSULTING

Chameleon Pharma Consulting ist der Pharma Beratungsexperte für M & A, Sales & Marketing, Vertrieb, Regulatory, R & D in der Region GUS (Russland, Ukraine, Kasachstan, Usbekistan, Weißrussland etc.) und Ost Europa (Polen, ...
DRUCKEN| VERSENDEN | RSS-FEED |
SOCIAL WEB
PRESSEFACH
Chameleon Pharma Consulting
Am Tempelhofer Berg 6
10965 Berlin
zum Pressefach
Anzeige
PRESSEARCHIV
Anzeige
BUSINESS-SERVICES
© novo per motio KG